Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter

Journal of Nuclear Medicine

Volumn 37, Issue 7, 1996, Pages 1207-1214

  Jagust, William J ^a   Eberling, Jamie L ^b   Biegon, Anat ^a   Taylor, Scott E ^b   VanBrocklin, Henry F ^b   Jordan, Shaun ^b   Hanrahan, Stephen M ^b   Roberts, Jeffrey A ^b   Brennan, Kathleen M ^b   Mathis, Chester A ^b  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b NONE

Author keywords

iodine 123 5 iodo 6 nitroquipazine; serotonin transporter

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 IODO 6 NITROQUIPAZINE I 123; 5 IODO 6 NITROQUIPAZINE I 125; NEUROTOXIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MACACA; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SEROTONINERGIC TRANSMISSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CARRIER PROTEINS; IODINE RADIOISOTOPES; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NERVE TISSUE PROTEINS; QUIPAZINE; SEROTONIN; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 10144229103     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. D'Amato RJ, Zweig RM, Whitehouse PJ, et al. Aminergic systems in Alzheimer's disease and Parkinson's disease. Ann Neurol 1987;22:229-236.
2. Halliday GM, Li YW, Blumbergs PC, et al. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol 1990;27:373-385.
3. Mayeux R, Stern Y, Cote L, Williams JBW. Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology 1984;34:642-646.
4. Zubenko GS, Moossy J, Martinez AJ, et al. Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol 1991;48:619-624.
5. Meltzer HY, Lowy MT. The serotonin hypothesis of depression. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York, NY: Raven Press; 1987:513-526.
6. Kuhar MJ, Aghajanian GK. Selective accumulation of 3H-serotonin by nerve terminals of raphe neurones: an autoradiographic study. Nature 1973;241:187-189.
7. Kuhar MJ, Roth RH, Aghajanian GK. Synaptosomes from forebrains of rats with midbrain raphe lesions: selective reduction of serotonin uptake. J Pharmacol Exp Ther 1972;181:36-45.
8. Kuhar MJ, Aghajanian GK, Roth RH. Tryptophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphe lesion: correlation with serotonin levels and histochemical fluorescence. Brain Res 1972;44: 165-176.
9. Suehiro M, Scheffel U, Dannals RF, et al. A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z. J Nucl Med 1993;34:120-127.
10. Scheffel U, Ricaurte GA. Paroxetine as an in vivo indicator of 3,4-methyl-enedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand? Brain Res 1990;527:89-95.
11. Kung MP, Chumpradit S, Panyachotipun C, et al. Radioiodinated analogs of fluoxetine: potential agents for imaging serotonin reuptake sites with SPECT. J Nucl Med 1991;32:964.
12. Chumpradit S, Kung MP, Panyachotipun C, et al. Iodinated tomoxetine derivatives as selective ligands for serotonin and norepinephrine uptake sites. J Med Chem 1992;35: 4492-4497.
13. Soucy JP, Lafaille F, Lemoine P, et al. Validation of the transporter ligand cyanoimipramine as a marker of serotonin innervation density in brain. J Nucl Med 1994;35: 1822-1830.
14. Farde L, Halldin C, Muller L, et al. PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain. Synapse 1994;16:93-103.
15. Suehiro M, Scheffel U, Dannals RF, et al. Synthesis and biodistribution of a new radiotracer for in vivo labeling of serotonin uptake sites by PET, cis-N,N-[11C]dimethyl-3-(2′,4′-dichlorophenyl)-indanamine (cis-[11C]DDP1). Nucl Med Biol 1992;19: 549-553.
16. Baldwin RM, Zea-Ponce Y, Zoghbi SS, et al. Evaluation of the monoamine uptake site ligand [123I]methyl 3beta-(4-iodophenyl)-tropane-2 beta-carboxylate ([123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI. Nucl Med Biol 1993;20:597-606.
17. Kung MP, Chumpradit S, Billings J, Kung H. 4-Iodotomoxetine: a novel ligand for serotonin uptake sites. Life Sci 1992;51:95-106.
18. 3H]-6-nitroquipazine. J Pharmacol Exp Ther 1990;255:146-153.
19. 125I]5-iodo-6-nitro-2-piperazinylquinoline - a potent and selective ligand for the serotonin uptake complex. Eur J Pharmacol 1992;210:103-104.
20. 125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytryptamine uptake complex I. In vitro studies. Brain Res 1993;619:229-235.
21. 125I]5-Iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytryptamine uptake complex II. In vivo studies in rats Brain Res 1993;619:236-246
22. 123I]5-iodo-6-nitroquipazine. European J Pharmacol 1993;242:189-193.
23. Chumpradit S, Kung M-P, Billings JJ, Kung HF. Synthesis and resolution of (±)-7-chloro-8-hydroxy-1-(3′-iodophenyl)-3-methyl-2,3,4,5- tetrahydro-1H-3-benzazepine (TISCH): a high affinity and selective iodinated ligand for CNS D1 dopamine receptor. J Med Chem 1991;34:877.
24. Martin DC, Introna RP, Aronstam RS. Inhibition of neuronal 5-HT uptake by ketamine, but not halothane, involves disruption of substrate recognition by the transporter. Neurosci Lett 1990;112:99-103.
25. Winters WD, Kado RT, Adey WR. A stereotaxic brain atlas for macaca nemestrina. Berkeley, CA: University of California Press; 1969.
26. Kusama T, Mabuchi M. Stereotaxic atlas of the brain of macaca fuscata. Tokyo, Japan: University of Tokyo Press; 1970.
27. Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol Rev 1992;72:165-229.
28. 3H]paroxetine. Neuroscience 1988;27:473-496.
29. Morrison JH, Foote SL, Molliver ME, et al. Noradrenergic and serotonergic fibers innervate complementary layers in monkey primary visual cortex: an immunohistochemical study. Proc Natl Acad Sci 1982;79:2401-2405.
30. Lavoie B, Parent A. Serotonergic innervation of the thalamus in the primate: an immunohistochemical study. J Comp Neurol 1991;312:1-18.
31. Azmitia EC, Gannon PJ. The primate serotonergic system: a review of human and animal studies and a report on macaca fascicularis. In: Fahn S, ed. Advances in neurology, vol. 43: myoclonus. New York, NY: Raven Press; 1986:407-468.
32. Ricaurte GA, DeLanney LE, Irwin I, Langston JW. Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res 1988;446:165-168.
33. Ricaurte GA, Martello AL, Katz JL, Martello MB. Lasting effects of (±)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J Pharm Exp Ther 1992;261:616-622.
34. Wilson MA, Ricaurte GA, Molliver ME. Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine. Neuroscience 1989;28:121-137.
35. Ali SF, Newport GD, Scallet AC, et al. Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate. Neurotoxicol Teratol 1993;15:91-96.
36. 11C](±)McN5652. Synapse 1995; 20:37-43.
37. Cline EJ, Scheffel U, Boja JW, et al. In vivo binding of [125I]RTI-55 to dopamine transporters: pharmacology and regional distribution with autoradiography. Synapse 1992;12:37-46.
38. 123I] beta-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 1994;14:982-994.
39. Innis RB, Seibyl JP, Scanley BE, et al. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proc Nat Acad Sci 1993;90:11965-11969.
40. 123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 1993;13:295-309.